NCT05855577View on ClinicalTrials.gov

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Parkinson DiseaseGait AnalysisTherapy, Directly ObservedMetabolic Disease

Interventions

DRUG

Terazosin

Treatment of Terazosine vs placebo and Lisosan-G vs placebo in cross-over double-blind, double-dummy

All Listed Sponsors

collaborator

Università Foro Italico Roma

OTHER

collaborator

CNR Pisa

UNKNOWN

lead

I.R.C.C.S. Fondazione Santa Lucia

OTHER

NCT05855577 - Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients | Biotech Hunter | Biotech Hunter